Allergan (AGN) Debt/EBITDA US GAAP (year values) |
|||||||||
2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 4.34 | 0.93 | -10.1 | 27.6 | 9.73 | 6.23 | |||
Changes by years, y/y, % | -57% | -79% | -1 189% | -373% | -65% | -0.6% |
Allergan. Debt/EBITDA
Allergan. Debt/EBITDA, changes, %
Allergan (AGN) Debt/EBITDA US GAAP (quarter values) |
||||||||
2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | LTM ? | |||
Debt/EBITDA | -20.6 | -8.76 | -5.32 | 9.73 | 6.23 | 6.23 | ||
Changes by years, y/y, % | -313% | -221% | -309% | -64% | -130% | |||
Changes by quarters, q/q, % | -176% | -57% | -39% | -283% | -36% |